Global TCR-engineered T Cell Therapy Supply, Demand and Key Producers, 2026-2032
The global TCR-engineered T Cell Therapy market size is expected to reach $ 2886 million by 2032, rising at a market growth of 23.7% CAGR during the forecast period (2026-2032).
TCR-engineered T Cell Therapy, or TCR-T cell therapy, is a personalized cellular therapy that uses patient-derived or donor-derived T cells engineered to express specific T cell receptors capable of recognizing disease-associated peptide antigens presented by HLA molecules. Unlike CAR-T therapies, which mainly target cell-surface antigens, TCR-T therapies can recognize intracellular antigen-derived peptides, giving them broader potential in solid tumors, virus-associated cancers, and other difficult-to-treat diseases. The process typically includes T cell collection, TCR discovery and engineering, viral or non-viral gene transfer, cell expansion, quality control, and reinfusion, making it a high-barrier, clinically complex, and highly promising frontier in immune cell therapy.The average gross profit margin of this product is 70%.
The global TCR-engineered T Cell Therapy market is driven by clinical demand, technology upgrades and regulatory access. Leading companies usually build barriers through core technology platforms, approvals or clinical evidence, manufacturing quality systems and channel coverage. Chinese manufacturers have advantages in cost, local clinical resources, registration execution and supply-chain response, while still improving in premium components, overseas certification, long-term clinical evidence and international branding.
Product competition is moving from stand-alone products to platform-based, bundled and scenario-specific solutions. Hospitals, laboratories, research institutions, pharmaceutical companies and end users have different requirements for performance, price, stability, automation and accessibility. Therefore, the directory classification should cover product type, technology route, performance grade and supply form while avoiding overlap among subsegments.
Future growth will be supported by expanding diagnosis and treatment demand, improving reimbursement and payment systems, domestic substitution, growth in emerging overseas markets and product upgrades. Key risks include lengthy approval cycles, high clinical validation costs, pricing pressure, stricter compliance requirements, supply volatility of key materials or components, and uncertainty around technology substitution. Companies with manufacturing scale, clinical evidence, compliance systems and multi-region sales capabilities are expected to maintain stronger positions.
This report studies the global TCR-engineered T Cell Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for TCR-engineered T Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of TCR-engineered T Cell Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global TCR-engineered T Cell Therapy total market, 2021-2032, (USD Million)
Global TCR-engineered T Cell Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: TCR-engineered T Cell Therapy total market, key domestic companies, and share, (USD Million)
Global TCR-engineered T Cell Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global TCR-engineered T Cell Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global TCR-engineered T Cell Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global TCR-engineered T Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adaptimmune, Immatics, TScan Therapeutics, Medigene, Triumvira Immunologics, 2seventy Bio, BioNTech, Gilead Sciences, Lion TCR, Xiangxue Life Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world TCR-engineered T Cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global TCR-engineered T Cell Therapy Market, By Region:
1. How big is the global TCR-engineered T Cell Therapy market?
2. What is the demand of the global TCR-engineered T Cell Therapy market?
3. What is the year over year growth of the global TCR-engineered T Cell Therapy market?
4. What is the total value of the global TCR-engineered T Cell Therapy market?
5. Who are the Major Players in the global TCR-engineered T Cell Therapy market?
6. What are the growth factors driving the market demand?
TCR-engineered T Cell Therapy, or TCR-T cell therapy, is a personalized cellular therapy that uses patient-derived or donor-derived T cells engineered to express specific T cell receptors capable of recognizing disease-associated peptide antigens presented by HLA molecules. Unlike CAR-T therapies, which mainly target cell-surface antigens, TCR-T therapies can recognize intracellular antigen-derived peptides, giving them broader potential in solid tumors, virus-associated cancers, and other difficult-to-treat diseases. The process typically includes T cell collection, TCR discovery and engineering, viral or non-viral gene transfer, cell expansion, quality control, and reinfusion, making it a high-barrier, clinically complex, and highly promising frontier in immune cell therapy.The average gross profit margin of this product is 70%.
The global TCR-engineered T Cell Therapy market is driven by clinical demand, technology upgrades and regulatory access. Leading companies usually build barriers through core technology platforms, approvals or clinical evidence, manufacturing quality systems and channel coverage. Chinese manufacturers have advantages in cost, local clinical resources, registration execution and supply-chain response, while still improving in premium components, overseas certification, long-term clinical evidence and international branding.
Product competition is moving from stand-alone products to platform-based, bundled and scenario-specific solutions. Hospitals, laboratories, research institutions, pharmaceutical companies and end users have different requirements for performance, price, stability, automation and accessibility. Therefore, the directory classification should cover product type, technology route, performance grade and supply form while avoiding overlap among subsegments.
Future growth will be supported by expanding diagnosis and treatment demand, improving reimbursement and payment systems, domestic substitution, growth in emerging overseas markets and product upgrades. Key risks include lengthy approval cycles, high clinical validation costs, pricing pressure, stricter compliance requirements, supply volatility of key materials or components, and uncertainty around technology substitution. Companies with manufacturing scale, clinical evidence, compliance systems and multi-region sales capabilities are expected to maintain stronger positions.
This report studies the global TCR-engineered T Cell Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for TCR-engineered T Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of TCR-engineered T Cell Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global TCR-engineered T Cell Therapy total market, 2021-2032, (USD Million)
Global TCR-engineered T Cell Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: TCR-engineered T Cell Therapy total market, key domestic companies, and share, (USD Million)
Global TCR-engineered T Cell Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global TCR-engineered T Cell Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global TCR-engineered T Cell Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global TCR-engineered T Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adaptimmune, Immatics, TScan Therapeutics, Medigene, Triumvira Immunologics, 2seventy Bio, BioNTech, Gilead Sciences, Lion TCR, Xiangxue Life Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world TCR-engineered T Cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global TCR-engineered T Cell Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Autologous TCR-T
- Allogeneic TCR-T
- Gene-Edited TCR-T
- TCR-NK Or Hybrid Cell Therapy
- TCR Screening Reagents
- Other
- NY-ESO-1 Targeted
- MAGE Family Targeted
- AFP Targeted
- HPV Or Viral Antigen Targeted
- Neoantigen Targeted
- Other
- Cell Therapy Product
- GMP Manufacturing Service
- Vector Or Editing Reagent
- Companion Testing
- Cryopreserved Product
- Other
- Synovial Sarcoma
- Melanoma
- Liver Cancer
- Lung Cancer
- Gastric And Esophageal Cancer
- Other Solid Tumors
- Other
- Adaptimmune
- Immatics
- TScan Therapeutics
- Medigene
- Triumvira Immunologics
- 2seventy Bio
- BioNTech
- Gilead Sciences
- Lion TCR
- Xiangxue Life Sciences
- JW Therapeutics
- Gracell Biotechnologies
- CARSgen Therapeutics
- Hrain Biotechnology
1. How big is the global TCR-engineered T Cell Therapy market?
2. What is the demand of the global TCR-engineered T Cell Therapy market?
3. What is the year over year growth of the global TCR-engineered T Cell Therapy market?
4. What is the total value of the global TCR-engineered T Cell Therapy market?
5. Who are the Major Players in the global TCR-engineered T Cell Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 TCR-engineered T Cell Therapy Introduction
1.2 World TCR-engineered T Cell Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World TCR-engineered T Cell Therapy Total Market by Region (by Headquarter Location)
1.3.1 World TCR-engineered T Cell Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.3.3 China Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.3.4 Europe Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.3.5 Japan Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.3.8 India Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 TCR-engineered T Cell Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.2 World TCR-engineered T Cell Therapy Consumption Value by Region
2.2.1 World TCR-engineered T Cell Therapy Consumption Value by Region (2021-2026)
2.2.2 World TCR-engineered T Cell Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.4 China TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.5 Europe TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.6 Japan TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.7 South Korea TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.8 ASEAN TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.9 India TCR-engineered T Cell Therapy Consumption Value (2021-2032)
3 WORLD TCR-ENGINEERED T CELL THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World TCR-engineered T Cell Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global TCR-engineered T Cell Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for TCR-engineered T Cell Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for TCR-engineered T Cell Therapy in 2025
3.3 TCR-engineered T Cell Therapy Company Evaluation Quadrant
3.4 TCR-engineered T Cell Therapy Market: Overall Company Footprint Analysis
3.4.1 TCR-engineered T Cell Therapy Market: Region Footprint
3.4.2 TCR-engineered T Cell Therapy Market: Company Product Type Footprint
3.4.3 TCR-engineered T Cell Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: TCR-engineered T Cell Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: TCR-engineered T Cell Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: TCR-engineered T Cell Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: TCR-engineered T Cell Therapy Consumption Value Comparison
4.2.1 United States VS China: TCR-engineered T Cell Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: TCR-engineered T Cell Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based TCR-engineered T Cell Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based TCR-engineered T Cell Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies TCR-engineered T Cell Therapy Revenue, (2021-2026)
4.4 China Based Companies TCR-engineered T Cell Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based TCR-engineered T Cell Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies TCR-engineered T Cell Therapy Revenue, (2021-2026)
4.5 Rest of World Based TCR-engineered T Cell Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based TCR-engineered T Cell Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies TCR-engineered T Cell Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World TCR-engineered T Cell Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Autologous TCR-T
5.2.2 Allogeneic TCR-T
5.2.3 Gene-Edited TCR-T
5.2.4 TCR-NK Or Hybrid Cell Therapy
5.2.5 TCR Screening Reagents
5.2.6 Other
5.3 Market Segment by Type
5.3.1 World TCR-engineered T Cell Therapy Market Size by Type (2021-2026)
5.3.2 World TCR-engineered T Cell Therapy Market Size by Type (2027-2032)
5.3.3 World TCR-engineered T Cell Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TARGET ANTIGEN
6.1 World TCR-engineered T Cell Therapy Market Size Overview by Target Antigen: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Antigen
6.2.1 NY-ESO-1 Targeted
6.2.2 MAGE Family Targeted
6.2.3 AFP Targeted
6.2.4 HPV Or Viral Antigen Targeted
6.2.5 Neoantigen Targeted
6.2.6 Other
6.3 Market Segment by Target Antigen
6.3.1 World TCR-engineered T Cell Therapy Market Size by Target Antigen (2021-2026)
6.3.2 World TCR-engineered T Cell Therapy Market Size by Target Antigen (2027-2032)
6.3.3 World TCR-engineered T Cell Therapy Market Size Market Share by Target Antigen (2027-2032)
7 MARKET ANALYSIS BY PRODUCT FORM
7.1 World TCR-engineered T Cell Therapy Market Size Overview by Product Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Form
7.2.1 Cell Therapy Product
7.2.2 GMP Manufacturing Service
7.2.3 Vector Or Editing Reagent
7.2.4 Companion Testing
7.2.5 Cryopreserved Product
7.2.6 Other
7.3 Market Segment by Product Form
7.3.1 World TCR-engineered T Cell Therapy Market Size by Product Form (2021-2026)
7.3.2 World TCR-engineered T Cell Therapy Market Size by Product Form (2027-2032)
7.3.3 World TCR-engineered T Cell Therapy Market Size Market Share by Product Form (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World TCR-engineered T Cell Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Synovial Sarcoma
8.2.2 Melanoma
8.2.3 Liver Cancer
8.2.4 Lung Cancer
8.2.5 Gastric And Esophageal Cancer
8.2.6 Other Solid Tumors
8.2.7 Other
8.3 Market Segment by Application
8.3.1 World TCR-engineered T Cell Therapy Market Size by Application (2021-2026)
8.3.2 World TCR-engineered T Cell Therapy Market Size by Application (2027-2032)
8.3.3 World TCR-engineered T Cell Therapy Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Adaptimmune
9.1.1 Adaptimmune Details
9.1.2 Adaptimmune Major Business
9.1.3 Adaptimmune TCR-engineered T Cell Therapy Product and Services
9.1.4 Adaptimmune TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Adaptimmune Recent Developments/Updates
9.1.6 Adaptimmune Competitive Strengths & Weaknesses
9.2 Immatics
9.2.1 Immatics Details
9.2.2 Immatics Major Business
9.2.3 Immatics TCR-engineered T Cell Therapy Product and Services
9.2.4 Immatics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Immatics Recent Developments/Updates
9.2.6 Immatics Competitive Strengths & Weaknesses
9.3 TScan Therapeutics
9.3.1 TScan Therapeutics Details
9.3.2 TScan Therapeutics Major Business
9.3.3 TScan Therapeutics TCR-engineered T Cell Therapy Product and Services
9.3.4 TScan Therapeutics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 TScan Therapeutics Recent Developments/Updates
9.3.6 TScan Therapeutics Competitive Strengths & Weaknesses
9.4 Medigene
9.4.1 Medigene Details
9.4.2 Medigene Major Business
9.4.3 Medigene TCR-engineered T Cell Therapy Product and Services
9.4.4 Medigene TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Medigene Recent Developments/Updates
9.4.6 Medigene Competitive Strengths & Weaknesses
9.5 Triumvira Immunologics
9.5.1 Triumvira Immunologics Details
9.5.2 Triumvira Immunologics Major Business
9.5.3 Triumvira Immunologics TCR-engineered T Cell Therapy Product and Services
9.5.4 Triumvira Immunologics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Triumvira Immunologics Recent Developments/Updates
9.5.6 Triumvira Immunologics Competitive Strengths & Weaknesses
9.6 2seventy Bio
9.6.1 2seventy Bio Details
9.6.2 2seventy Bio Major Business
9.6.3 2seventy Bio TCR-engineered T Cell Therapy Product and Services
9.6.4 2seventy Bio TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 2seventy Bio Recent Developments/Updates
9.6.6 2seventy Bio Competitive Strengths & Weaknesses
9.7 BioNTech
9.7.1 BioNTech Details
9.7.2 BioNTech Major Business
9.7.3 BioNTech TCR-engineered T Cell Therapy Product and Services
9.7.4 BioNTech TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 BioNTech Recent Developments/Updates
9.7.6 BioNTech Competitive Strengths & Weaknesses
9.8 Gilead Sciences
9.8.1 Gilead Sciences Details
9.8.2 Gilead Sciences Major Business
9.8.3 Gilead Sciences TCR-engineered T Cell Therapy Product and Services
9.8.4 Gilead Sciences TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Gilead Sciences Recent Developments/Updates
9.8.6 Gilead Sciences Competitive Strengths & Weaknesses
9.9 Lion TCR
9.9.1 Lion TCR Details
9.9.2 Lion TCR Major Business
9.9.3 Lion TCR TCR-engineered T Cell Therapy Product and Services
9.9.4 Lion TCR TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Lion TCR Recent Developments/Updates
9.9.6 Lion TCR Competitive Strengths & Weaknesses
9.10 Xiangxue Life Sciences
9.10.1 Xiangxue Life Sciences Details
9.10.2 Xiangxue Life Sciences Major Business
9.10.3 Xiangxue Life Sciences TCR-engineered T Cell Therapy Product and Services
9.10.4 Xiangxue Life Sciences TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Xiangxue Life Sciences Recent Developments/Updates
9.10.6 Xiangxue Life Sciences Competitive Strengths & Weaknesses
9.11 JW Therapeutics
9.11.1 JW Therapeutics Details
9.11.2 JW Therapeutics Major Business
9.11.3 JW Therapeutics TCR-engineered T Cell Therapy Product and Services
9.11.4 JW Therapeutics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 JW Therapeutics Recent Developments/Updates
9.11.6 JW Therapeutics Competitive Strengths & Weaknesses
9.12 Gracell Biotechnologies
9.12.1 Gracell Biotechnologies Details
9.12.2 Gracell Biotechnologies Major Business
9.12.3 Gracell Biotechnologies TCR-engineered T Cell Therapy Product and Services
9.12.4 Gracell Biotechnologies TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Gracell Biotechnologies Recent Developments/Updates
9.12.6 Gracell Biotechnologies Competitive Strengths & Weaknesses
9.13 CARSgen Therapeutics
9.13.1 CARSgen Therapeutics Details
9.13.2 CARSgen Therapeutics Major Business
9.13.3 CARSgen Therapeutics TCR-engineered T Cell Therapy Product and Services
9.13.4 CARSgen Therapeutics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 CARSgen Therapeutics Recent Developments/Updates
9.13.6 CARSgen Therapeutics Competitive Strengths & Weaknesses
9.14 Hrain Biotechnology
9.14.1 Hrain Biotechnology Details
9.14.2 Hrain Biotechnology Major Business
9.14.3 Hrain Biotechnology TCR-engineered T Cell Therapy Product and Services
9.14.4 Hrain Biotechnology TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Hrain Biotechnology Recent Developments/Updates
9.14.6 Hrain Biotechnology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 TCR-engineered T Cell Therapy Industry Chain
10.2 TCR-engineered T Cell Therapy Upstream Analysis
10.3 TCR-engineered T Cell Therapy Midstream Analysis
10.4 TCR-engineered T Cell Therapy Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 TCR-engineered T Cell Therapy Introduction
1.2 World TCR-engineered T Cell Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World TCR-engineered T Cell Therapy Total Market by Region (by Headquarter Location)
1.3.1 World TCR-engineered T Cell Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.3.3 China Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.3.4 Europe Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.3.5 Japan Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.3.8 India Based Company TCR-engineered T Cell Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 TCR-engineered T Cell Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.2 World TCR-engineered T Cell Therapy Consumption Value by Region
2.2.1 World TCR-engineered T Cell Therapy Consumption Value by Region (2021-2026)
2.2.2 World TCR-engineered T Cell Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.4 China TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.5 Europe TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.6 Japan TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.7 South Korea TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.8 ASEAN TCR-engineered T Cell Therapy Consumption Value (2021-2032)
2.9 India TCR-engineered T Cell Therapy Consumption Value (2021-2032)
3 WORLD TCR-ENGINEERED T CELL THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World TCR-engineered T Cell Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global TCR-engineered T Cell Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for TCR-engineered T Cell Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for TCR-engineered T Cell Therapy in 2025
3.3 TCR-engineered T Cell Therapy Company Evaluation Quadrant
3.4 TCR-engineered T Cell Therapy Market: Overall Company Footprint Analysis
3.4.1 TCR-engineered T Cell Therapy Market: Region Footprint
3.4.2 TCR-engineered T Cell Therapy Market: Company Product Type Footprint
3.4.3 TCR-engineered T Cell Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: TCR-engineered T Cell Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: TCR-engineered T Cell Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: TCR-engineered T Cell Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: TCR-engineered T Cell Therapy Consumption Value Comparison
4.2.1 United States VS China: TCR-engineered T Cell Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: TCR-engineered T Cell Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based TCR-engineered T Cell Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based TCR-engineered T Cell Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies TCR-engineered T Cell Therapy Revenue, (2021-2026)
4.4 China Based Companies TCR-engineered T Cell Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based TCR-engineered T Cell Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies TCR-engineered T Cell Therapy Revenue, (2021-2026)
4.5 Rest of World Based TCR-engineered T Cell Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based TCR-engineered T Cell Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies TCR-engineered T Cell Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World TCR-engineered T Cell Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Autologous TCR-T
5.2.2 Allogeneic TCR-T
5.2.3 Gene-Edited TCR-T
5.2.4 TCR-NK Or Hybrid Cell Therapy
5.2.5 TCR Screening Reagents
5.2.6 Other
5.3 Market Segment by Type
5.3.1 World TCR-engineered T Cell Therapy Market Size by Type (2021-2026)
5.3.2 World TCR-engineered T Cell Therapy Market Size by Type (2027-2032)
5.3.3 World TCR-engineered T Cell Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TARGET ANTIGEN
6.1 World TCR-engineered T Cell Therapy Market Size Overview by Target Antigen: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Antigen
6.2.1 NY-ESO-1 Targeted
6.2.2 MAGE Family Targeted
6.2.3 AFP Targeted
6.2.4 HPV Or Viral Antigen Targeted
6.2.5 Neoantigen Targeted
6.2.6 Other
6.3 Market Segment by Target Antigen
6.3.1 World TCR-engineered T Cell Therapy Market Size by Target Antigen (2021-2026)
6.3.2 World TCR-engineered T Cell Therapy Market Size by Target Antigen (2027-2032)
6.3.3 World TCR-engineered T Cell Therapy Market Size Market Share by Target Antigen (2027-2032)
7 MARKET ANALYSIS BY PRODUCT FORM
7.1 World TCR-engineered T Cell Therapy Market Size Overview by Product Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Form
7.2.1 Cell Therapy Product
7.2.2 GMP Manufacturing Service
7.2.3 Vector Or Editing Reagent
7.2.4 Companion Testing
7.2.5 Cryopreserved Product
7.2.6 Other
7.3 Market Segment by Product Form
7.3.1 World TCR-engineered T Cell Therapy Market Size by Product Form (2021-2026)
7.3.2 World TCR-engineered T Cell Therapy Market Size by Product Form (2027-2032)
7.3.3 World TCR-engineered T Cell Therapy Market Size Market Share by Product Form (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World TCR-engineered T Cell Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Synovial Sarcoma
8.2.2 Melanoma
8.2.3 Liver Cancer
8.2.4 Lung Cancer
8.2.5 Gastric And Esophageal Cancer
8.2.6 Other Solid Tumors
8.2.7 Other
8.3 Market Segment by Application
8.3.1 World TCR-engineered T Cell Therapy Market Size by Application (2021-2026)
8.3.2 World TCR-engineered T Cell Therapy Market Size by Application (2027-2032)
8.3.3 World TCR-engineered T Cell Therapy Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Adaptimmune
9.1.1 Adaptimmune Details
9.1.2 Adaptimmune Major Business
9.1.3 Adaptimmune TCR-engineered T Cell Therapy Product and Services
9.1.4 Adaptimmune TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Adaptimmune Recent Developments/Updates
9.1.6 Adaptimmune Competitive Strengths & Weaknesses
9.2 Immatics
9.2.1 Immatics Details
9.2.2 Immatics Major Business
9.2.3 Immatics TCR-engineered T Cell Therapy Product and Services
9.2.4 Immatics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Immatics Recent Developments/Updates
9.2.6 Immatics Competitive Strengths & Weaknesses
9.3 TScan Therapeutics
9.3.1 TScan Therapeutics Details
9.3.2 TScan Therapeutics Major Business
9.3.3 TScan Therapeutics TCR-engineered T Cell Therapy Product and Services
9.3.4 TScan Therapeutics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 TScan Therapeutics Recent Developments/Updates
9.3.6 TScan Therapeutics Competitive Strengths & Weaknesses
9.4 Medigene
9.4.1 Medigene Details
9.4.2 Medigene Major Business
9.4.3 Medigene TCR-engineered T Cell Therapy Product and Services
9.4.4 Medigene TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Medigene Recent Developments/Updates
9.4.6 Medigene Competitive Strengths & Weaknesses
9.5 Triumvira Immunologics
9.5.1 Triumvira Immunologics Details
9.5.2 Triumvira Immunologics Major Business
9.5.3 Triumvira Immunologics TCR-engineered T Cell Therapy Product and Services
9.5.4 Triumvira Immunologics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Triumvira Immunologics Recent Developments/Updates
9.5.6 Triumvira Immunologics Competitive Strengths & Weaknesses
9.6 2seventy Bio
9.6.1 2seventy Bio Details
9.6.2 2seventy Bio Major Business
9.6.3 2seventy Bio TCR-engineered T Cell Therapy Product and Services
9.6.4 2seventy Bio TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 2seventy Bio Recent Developments/Updates
9.6.6 2seventy Bio Competitive Strengths & Weaknesses
9.7 BioNTech
9.7.1 BioNTech Details
9.7.2 BioNTech Major Business
9.7.3 BioNTech TCR-engineered T Cell Therapy Product and Services
9.7.4 BioNTech TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 BioNTech Recent Developments/Updates
9.7.6 BioNTech Competitive Strengths & Weaknesses
9.8 Gilead Sciences
9.8.1 Gilead Sciences Details
9.8.2 Gilead Sciences Major Business
9.8.3 Gilead Sciences TCR-engineered T Cell Therapy Product and Services
9.8.4 Gilead Sciences TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Gilead Sciences Recent Developments/Updates
9.8.6 Gilead Sciences Competitive Strengths & Weaknesses
9.9 Lion TCR
9.9.1 Lion TCR Details
9.9.2 Lion TCR Major Business
9.9.3 Lion TCR TCR-engineered T Cell Therapy Product and Services
9.9.4 Lion TCR TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Lion TCR Recent Developments/Updates
9.9.6 Lion TCR Competitive Strengths & Weaknesses
9.10 Xiangxue Life Sciences
9.10.1 Xiangxue Life Sciences Details
9.10.2 Xiangxue Life Sciences Major Business
9.10.3 Xiangxue Life Sciences TCR-engineered T Cell Therapy Product and Services
9.10.4 Xiangxue Life Sciences TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Xiangxue Life Sciences Recent Developments/Updates
9.10.6 Xiangxue Life Sciences Competitive Strengths & Weaknesses
9.11 JW Therapeutics
9.11.1 JW Therapeutics Details
9.11.2 JW Therapeutics Major Business
9.11.3 JW Therapeutics TCR-engineered T Cell Therapy Product and Services
9.11.4 JW Therapeutics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 JW Therapeutics Recent Developments/Updates
9.11.6 JW Therapeutics Competitive Strengths & Weaknesses
9.12 Gracell Biotechnologies
9.12.1 Gracell Biotechnologies Details
9.12.2 Gracell Biotechnologies Major Business
9.12.3 Gracell Biotechnologies TCR-engineered T Cell Therapy Product and Services
9.12.4 Gracell Biotechnologies TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Gracell Biotechnologies Recent Developments/Updates
9.12.6 Gracell Biotechnologies Competitive Strengths & Weaknesses
9.13 CARSgen Therapeutics
9.13.1 CARSgen Therapeutics Details
9.13.2 CARSgen Therapeutics Major Business
9.13.3 CARSgen Therapeutics TCR-engineered T Cell Therapy Product and Services
9.13.4 CARSgen Therapeutics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 CARSgen Therapeutics Recent Developments/Updates
9.13.6 CARSgen Therapeutics Competitive Strengths & Weaknesses
9.14 Hrain Biotechnology
9.14.1 Hrain Biotechnology Details
9.14.2 Hrain Biotechnology Major Business
9.14.3 Hrain Biotechnology TCR-engineered T Cell Therapy Product and Services
9.14.4 Hrain Biotechnology TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Hrain Biotechnology Recent Developments/Updates
9.14.6 Hrain Biotechnology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 TCR-engineered T Cell Therapy Industry Chain
10.2 TCR-engineered T Cell Therapy Upstream Analysis
10.3 TCR-engineered T Cell Therapy Midstream Analysis
10.4 TCR-engineered T Cell Therapy Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World TCR-engineered T Cell Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World TCR-engineered T Cell Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World TCR-engineered T Cell Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World TCR-engineered T Cell Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World TCR-engineered T Cell Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World TCR-engineered T Cell Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World TCR-engineered T Cell Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World TCR-engineered T Cell Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World TCR-engineered T Cell Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key TCR-engineered T Cell Therapy Players in 2025
Table 12. World TCR-engineered T Cell Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global TCR-engineered T Cell Therapy Company Evaluation Quadrant
Table 14. Head Office of Key TCR-engineered T Cell Therapy Players
Table 15. TCR-engineered T Cell Therapy Market: Company Product Type Footprint
Table 16. TCR-engineered T Cell Therapy Market: Company Product Application Footprint
Table 17. TCR-engineered T Cell Therapy Mergers & Acquisitions Activity
Table 18. United States VS China TCR-engineered T Cell Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China TCR-engineered T Cell Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based TCR-engineered T Cell Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies TCR-engineered T Cell Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies TCR-engineered T Cell Therapy Revenue Market Share (2021-2026)
Table 23. China Based TCR-engineered T Cell Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies TCR-engineered T Cell Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies TCR-engineered T Cell Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based TCR-engineered T Cell Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies TCR-engineered T Cell Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies TCR-engineered T Cell Therapy Revenue Market Share (2021-2026)
Table 29. World TCR-engineered T Cell Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World TCR-engineered T Cell Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World TCR-engineered T Cell Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World TCR-engineered T Cell Therapy Market Size by Target Antigen, (USD Million), 2021 & 2025 & 2032
Table 33. World TCR-engineered T Cell Therapy Market Size Value by Target Antigen (2021-2026) & (USD Million)
Table 34. World TCR-engineered T Cell Therapy Market Size by Target Antigen (2027-2032) & (USD Million)
Table 35. World TCR-engineered T Cell Therapy Market Size by Product Form, (USD Million), 2021 & 2025 & 2032
Table 36. World TCR-engineered T Cell Therapy Market Size Value by Product Form (2021-2026) & (USD Million)
Table 37. World TCR-engineered T Cell Therapy Market Size by Product Form (2027-2032) & (USD Million)
Table 38. World TCR-engineered T Cell Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World TCR-engineered T Cell Therapy Market Size by Application (2021-2026) & (USD Million)
Table 40. World TCR-engineered T Cell Therapy Market Size by Application (2027-2032) & (USD Million)
Table 41. Adaptimmune Basic Information, Manufacturing Base and Competitors
Table 42. Adaptimmune Major Business
Table 43. Adaptimmune TCR-engineered T Cell Therapy Product and Services
Table 44. Adaptimmune TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Adaptimmune Recent Developments/Updates
Table 46. Adaptimmune Competitive Strengths & Weaknesses
Table 47. Immatics Basic Information, Manufacturing Base and Competitors
Table 48. Immatics Major Business
Table 49. Immatics TCR-engineered T Cell Therapy Product and Services
Table 50. Immatics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Immatics Recent Developments/Updates
Table 52. Immatics Competitive Strengths & Weaknesses
Table 53. TScan Therapeutics Basic Information, Manufacturing Base and Competitors
Table 54. TScan Therapeutics Major Business
Table 55. TScan Therapeutics TCR-engineered T Cell Therapy Product and Services
Table 56. TScan Therapeutics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. TScan Therapeutics Recent Developments/Updates
Table 58. TScan Therapeutics Competitive Strengths & Weaknesses
Table 59. Medigene Basic Information, Manufacturing Base and Competitors
Table 60. Medigene Major Business
Table 61. Medigene TCR-engineered T Cell Therapy Product and Services
Table 62. Medigene TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Medigene Recent Developments/Updates
Table 64. Medigene Competitive Strengths & Weaknesses
Table 65. Triumvira Immunologics Basic Information, Manufacturing Base and Competitors
Table 66. Triumvira Immunologics Major Business
Table 67. Triumvira Immunologics TCR-engineered T Cell Therapy Product and Services
Table 68. Triumvira Immunologics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Triumvira Immunologics Recent Developments/Updates
Table 70. Triumvira Immunologics Competitive Strengths & Weaknesses
Table 71. 2seventy Bio Basic Information, Manufacturing Base and Competitors
Table 72. 2seventy Bio Major Business
Table 73. 2seventy Bio TCR-engineered T Cell Therapy Product and Services
Table 74. 2seventy Bio TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. 2seventy Bio Recent Developments/Updates
Table 76. 2seventy Bio Competitive Strengths & Weaknesses
Table 77. BioNTech Basic Information, Manufacturing Base and Competitors
Table 78. BioNTech Major Business
Table 79. BioNTech TCR-engineered T Cell Therapy Product and Services
Table 80. BioNTech TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. BioNTech Recent Developments/Updates
Table 82. BioNTech Competitive Strengths & Weaknesses
Table 83. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 84. Gilead Sciences Major Business
Table 85. Gilead Sciences TCR-engineered T Cell Therapy Product and Services
Table 86. Gilead Sciences TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Gilead Sciences Recent Developments/Updates
Table 88. Gilead Sciences Competitive Strengths & Weaknesses
Table 89. Lion TCR Basic Information, Manufacturing Base and Competitors
Table 90. Lion TCR Major Business
Table 91. Lion TCR TCR-engineered T Cell Therapy Product and Services
Table 92. Lion TCR TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Lion TCR Recent Developments/Updates
Table 94. Lion TCR Competitive Strengths & Weaknesses
Table 95. Xiangxue Life Sciences Basic Information, Manufacturing Base and Competitors
Table 96. Xiangxue Life Sciences Major Business
Table 97. Xiangxue Life Sciences TCR-engineered T Cell Therapy Product and Services
Table 98. Xiangxue Life Sciences TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Xiangxue Life Sciences Recent Developments/Updates
Table 100. Xiangxue Life Sciences Competitive Strengths & Weaknesses
Table 101. JW Therapeutics Basic Information, Manufacturing Base and Competitors
Table 102. JW Therapeutics Major Business
Table 103. JW Therapeutics TCR-engineered T Cell Therapy Product and Services
Table 104. JW Therapeutics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. JW Therapeutics Recent Developments/Updates
Table 106. JW Therapeutics Competitive Strengths & Weaknesses
Table 107. Gracell Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 108. Gracell Biotechnologies Major Business
Table 109. Gracell Biotechnologies TCR-engineered T Cell Therapy Product and Services
Table 110. Gracell Biotechnologies TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Gracell Biotechnologies Recent Developments/Updates
Table 112. Gracell Biotechnologies Competitive Strengths & Weaknesses
Table 113. CARSgen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 114. CARSgen Therapeutics Major Business
Table 115. CARSgen Therapeutics TCR-engineered T Cell Therapy Product and Services
Table 116. CARSgen Therapeutics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. CARSgen Therapeutics Recent Developments/Updates
Table 118. CARSgen Therapeutics Competitive Strengths & Weaknesses
Table 119. Hrain Biotechnology Basic Information, Manufacturing Base and Competitors
Table 120. Hrain Biotechnology Major Business
Table 121. Hrain Biotechnology TCR-engineered T Cell Therapy Product and Services
Table 122. Hrain Biotechnology TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Hrain Biotechnology Recent Developments/Updates
Table 124. Hrain Biotechnology Competitive Strengths & Weaknesses
Table 125. Global Key Players of TCR-engineered T Cell Therapy Upstream (Raw Materials)
Table 126. Global TCR-engineered T Cell Therapy Typical Customers
Table 1. World TCR-engineered T Cell Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World TCR-engineered T Cell Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World TCR-engineered T Cell Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World TCR-engineered T Cell Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World TCR-engineered T Cell Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World TCR-engineered T Cell Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World TCR-engineered T Cell Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World TCR-engineered T Cell Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World TCR-engineered T Cell Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key TCR-engineered T Cell Therapy Players in 2025
Table 12. World TCR-engineered T Cell Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global TCR-engineered T Cell Therapy Company Evaluation Quadrant
Table 14. Head Office of Key TCR-engineered T Cell Therapy Players
Table 15. TCR-engineered T Cell Therapy Market: Company Product Type Footprint
Table 16. TCR-engineered T Cell Therapy Market: Company Product Application Footprint
Table 17. TCR-engineered T Cell Therapy Mergers & Acquisitions Activity
Table 18. United States VS China TCR-engineered T Cell Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China TCR-engineered T Cell Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based TCR-engineered T Cell Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies TCR-engineered T Cell Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies TCR-engineered T Cell Therapy Revenue Market Share (2021-2026)
Table 23. China Based TCR-engineered T Cell Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies TCR-engineered T Cell Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies TCR-engineered T Cell Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based TCR-engineered T Cell Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies TCR-engineered T Cell Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies TCR-engineered T Cell Therapy Revenue Market Share (2021-2026)
Table 29. World TCR-engineered T Cell Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World TCR-engineered T Cell Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World TCR-engineered T Cell Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World TCR-engineered T Cell Therapy Market Size by Target Antigen, (USD Million), 2021 & 2025 & 2032
Table 33. World TCR-engineered T Cell Therapy Market Size Value by Target Antigen (2021-2026) & (USD Million)
Table 34. World TCR-engineered T Cell Therapy Market Size by Target Antigen (2027-2032) & (USD Million)
Table 35. World TCR-engineered T Cell Therapy Market Size by Product Form, (USD Million), 2021 & 2025 & 2032
Table 36. World TCR-engineered T Cell Therapy Market Size Value by Product Form (2021-2026) & (USD Million)
Table 37. World TCR-engineered T Cell Therapy Market Size by Product Form (2027-2032) & (USD Million)
Table 38. World TCR-engineered T Cell Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World TCR-engineered T Cell Therapy Market Size by Application (2021-2026) & (USD Million)
Table 40. World TCR-engineered T Cell Therapy Market Size by Application (2027-2032) & (USD Million)
Table 41. Adaptimmune Basic Information, Manufacturing Base and Competitors
Table 42. Adaptimmune Major Business
Table 43. Adaptimmune TCR-engineered T Cell Therapy Product and Services
Table 44. Adaptimmune TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Adaptimmune Recent Developments/Updates
Table 46. Adaptimmune Competitive Strengths & Weaknesses
Table 47. Immatics Basic Information, Manufacturing Base and Competitors
Table 48. Immatics Major Business
Table 49. Immatics TCR-engineered T Cell Therapy Product and Services
Table 50. Immatics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Immatics Recent Developments/Updates
Table 52. Immatics Competitive Strengths & Weaknesses
Table 53. TScan Therapeutics Basic Information, Manufacturing Base and Competitors
Table 54. TScan Therapeutics Major Business
Table 55. TScan Therapeutics TCR-engineered T Cell Therapy Product and Services
Table 56. TScan Therapeutics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. TScan Therapeutics Recent Developments/Updates
Table 58. TScan Therapeutics Competitive Strengths & Weaknesses
Table 59. Medigene Basic Information, Manufacturing Base and Competitors
Table 60. Medigene Major Business
Table 61. Medigene TCR-engineered T Cell Therapy Product and Services
Table 62. Medigene TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Medigene Recent Developments/Updates
Table 64. Medigene Competitive Strengths & Weaknesses
Table 65. Triumvira Immunologics Basic Information, Manufacturing Base and Competitors
Table 66. Triumvira Immunologics Major Business
Table 67. Triumvira Immunologics TCR-engineered T Cell Therapy Product and Services
Table 68. Triumvira Immunologics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Triumvira Immunologics Recent Developments/Updates
Table 70. Triumvira Immunologics Competitive Strengths & Weaknesses
Table 71. 2seventy Bio Basic Information, Manufacturing Base and Competitors
Table 72. 2seventy Bio Major Business
Table 73. 2seventy Bio TCR-engineered T Cell Therapy Product and Services
Table 74. 2seventy Bio TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. 2seventy Bio Recent Developments/Updates
Table 76. 2seventy Bio Competitive Strengths & Weaknesses
Table 77. BioNTech Basic Information, Manufacturing Base and Competitors
Table 78. BioNTech Major Business
Table 79. BioNTech TCR-engineered T Cell Therapy Product and Services
Table 80. BioNTech TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. BioNTech Recent Developments/Updates
Table 82. BioNTech Competitive Strengths & Weaknesses
Table 83. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 84. Gilead Sciences Major Business
Table 85. Gilead Sciences TCR-engineered T Cell Therapy Product and Services
Table 86. Gilead Sciences TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Gilead Sciences Recent Developments/Updates
Table 88. Gilead Sciences Competitive Strengths & Weaknesses
Table 89. Lion TCR Basic Information, Manufacturing Base and Competitors
Table 90. Lion TCR Major Business
Table 91. Lion TCR TCR-engineered T Cell Therapy Product and Services
Table 92. Lion TCR TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Lion TCR Recent Developments/Updates
Table 94. Lion TCR Competitive Strengths & Weaknesses
Table 95. Xiangxue Life Sciences Basic Information, Manufacturing Base and Competitors
Table 96. Xiangxue Life Sciences Major Business
Table 97. Xiangxue Life Sciences TCR-engineered T Cell Therapy Product and Services
Table 98. Xiangxue Life Sciences TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Xiangxue Life Sciences Recent Developments/Updates
Table 100. Xiangxue Life Sciences Competitive Strengths & Weaknesses
Table 101. JW Therapeutics Basic Information, Manufacturing Base and Competitors
Table 102. JW Therapeutics Major Business
Table 103. JW Therapeutics TCR-engineered T Cell Therapy Product and Services
Table 104. JW Therapeutics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. JW Therapeutics Recent Developments/Updates
Table 106. JW Therapeutics Competitive Strengths & Weaknesses
Table 107. Gracell Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 108. Gracell Biotechnologies Major Business
Table 109. Gracell Biotechnologies TCR-engineered T Cell Therapy Product and Services
Table 110. Gracell Biotechnologies TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Gracell Biotechnologies Recent Developments/Updates
Table 112. Gracell Biotechnologies Competitive Strengths & Weaknesses
Table 113. CARSgen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 114. CARSgen Therapeutics Major Business
Table 115. CARSgen Therapeutics TCR-engineered T Cell Therapy Product and Services
Table 116. CARSgen Therapeutics TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. CARSgen Therapeutics Recent Developments/Updates
Table 118. CARSgen Therapeutics Competitive Strengths & Weaknesses
Table 119. Hrain Biotechnology Basic Information, Manufacturing Base and Competitors
Table 120. Hrain Biotechnology Major Business
Table 121. Hrain Biotechnology TCR-engineered T Cell Therapy Product and Services
Table 122. Hrain Biotechnology TCR-engineered T Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Hrain Biotechnology Recent Developments/Updates
Table 124. Hrain Biotechnology Competitive Strengths & Weaknesses
Table 125. Global Key Players of TCR-engineered T Cell Therapy Upstream (Raw Materials)
Table 126. Global TCR-engineered T Cell Therapy Typical Customers
LIST OF FIGURES
Figure 1. TCR-engineered T Cell Therapy Picture
Figure 2. World TCR-engineered T Cell Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World TCR-engineered T Cell Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World TCR-engineered T Cell Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World TCR-engineered T Cell Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 13. TCR-engineered T Cell Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World TCR-engineered T Cell Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of TCR-engineered T Cell Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for TCR-engineered T Cell Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for TCR-engineered T Cell Therapy Markets in 2025
Figure 27. United States VS China: TCR-engineered T Cell Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: TCR-engineered T Cell Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World TCR-engineered T Cell Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World TCR-engineered T Cell Therapy Market Size Market Share by Type in 2025
Figure 31. Autologous TCR-T
Figure 32. Allogeneic TCR-T
Figure 33. Gene-Edited TCR-T
Figure 34. TCR-NK Or Hybrid Cell Therapy
Figure 35. TCR Screening Reagents
Figure 36. Other
Figure 37. World TCR-engineered T Cell Therapy Market Size Market Share by Type (2021-2032)
Figure 38. World TCR-engineered T Cell Therapy Market Size by Target Antigen, (USD Million), 2021 & 2025 & 2032
Figure 39. World TCR-engineered T Cell Therapy Market Size Market Share by Target Antigen in 2025
Figure 40. NY-ESO-1 Targeted
Figure 41. MAGE Family Targeted
Figure 42. AFP Targeted
Figure 43. HPV Or Viral Antigen Targeted
Figure 44. Neoantigen Targeted
Figure 45. Other
Figure 46. World TCR-engineered T Cell Therapy Market Size Market Share by Target Antigen (2021-2032)
Figure 47. World TCR-engineered T Cell Therapy Market Size by Product Form, (USD Million), 2021 & 2025 & 2032
Figure 48. World TCR-engineered T Cell Therapy Market Size Market Share by Product Form in 2025
Figure 49. Cell Therapy Product
Figure 50. GMP Manufacturing Service
Figure 51. Vector Or Editing Reagent
Figure 52. Companion Testing
Figure 53. Cryopreserved Product
Figure 54. Other
Figure 55. World TCR-engineered T Cell Therapy Market Size Market Share by Product Form (2021-2032)
Figure 56. World TCR-engineered T Cell Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World TCR-engineered T Cell Therapy Market Size Market Share by Application in 2025
Figure 58. Synovial Sarcoma
Figure 59. Melanoma
Figure 60. Liver Cancer
Figure 61. Lung Cancer
Figure 62. Gastric And Esophageal Cancer
Figure 63. Other Solid Tumors
Figure 64. Other
Figure 65. World TCR-engineered T Cell Therapy Market Size Market Share by Application (2021-2032)
Figure 66. TCR-engineered T Cell Therapy Industrial Chain
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. TCR-engineered T Cell Therapy Picture
Figure 2. World TCR-engineered T Cell Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World TCR-engineered T Cell Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World TCR-engineered T Cell Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World TCR-engineered T Cell Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company TCR-engineered T Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 13. TCR-engineered T Cell Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World TCR-engineered T Cell Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India TCR-engineered T Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of TCR-engineered T Cell Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for TCR-engineered T Cell Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for TCR-engineered T Cell Therapy Markets in 2025
Figure 27. United States VS China: TCR-engineered T Cell Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: TCR-engineered T Cell Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World TCR-engineered T Cell Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World TCR-engineered T Cell Therapy Market Size Market Share by Type in 2025
Figure 31. Autologous TCR-T
Figure 32. Allogeneic TCR-T
Figure 33. Gene-Edited TCR-T
Figure 34. TCR-NK Or Hybrid Cell Therapy
Figure 35. TCR Screening Reagents
Figure 36. Other
Figure 37. World TCR-engineered T Cell Therapy Market Size Market Share by Type (2021-2032)
Figure 38. World TCR-engineered T Cell Therapy Market Size by Target Antigen, (USD Million), 2021 & 2025 & 2032
Figure 39. World TCR-engineered T Cell Therapy Market Size Market Share by Target Antigen in 2025
Figure 40. NY-ESO-1 Targeted
Figure 41. MAGE Family Targeted
Figure 42. AFP Targeted
Figure 43. HPV Or Viral Antigen Targeted
Figure 44. Neoantigen Targeted
Figure 45. Other
Figure 46. World TCR-engineered T Cell Therapy Market Size Market Share by Target Antigen (2021-2032)
Figure 47. World TCR-engineered T Cell Therapy Market Size by Product Form, (USD Million), 2021 & 2025 & 2032
Figure 48. World TCR-engineered T Cell Therapy Market Size Market Share by Product Form in 2025
Figure 49. Cell Therapy Product
Figure 50. GMP Manufacturing Service
Figure 51. Vector Or Editing Reagent
Figure 52. Companion Testing
Figure 53. Cryopreserved Product
Figure 54. Other
Figure 55. World TCR-engineered T Cell Therapy Market Size Market Share by Product Form (2021-2032)
Figure 56. World TCR-engineered T Cell Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World TCR-engineered T Cell Therapy Market Size Market Share by Application in 2025
Figure 58. Synovial Sarcoma
Figure 59. Melanoma
Figure 60. Liver Cancer
Figure 61. Lung Cancer
Figure 62. Gastric And Esophageal Cancer
Figure 63. Other Solid Tumors
Figure 64. Other
Figure 65. World TCR-engineered T Cell Therapy Market Size Market Share by Application (2021-2032)
Figure 66. TCR-engineered T Cell Therapy Industrial Chain
Figure 67. Methodology
Figure 68. Research Process and Data Source
